Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05233527 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Novosyn® Quick in Patients Undergoing Episiotomy Closure

Study acronym: RETRO-EPINOQ
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 300 to confirmed 229 · Primary completion date changed from estimate of Apr 2026 to Mar 26, 2026 · Site details revisedv11 Show 3 more changesShow less
    • Enrollment target: estimated 300 to confirmed 229
    • Primary completion date changed from estimate of Apr 2026 to Mar 26, 2026
    • Site details revised
  2. Primary completion date: Oct 2025 to Apr 2026 Completion date: May 2026 to Oct 2026v10 Show 1 more changeShow less
    • Completion date: May 2026 to Oct 2026
  3. Primary completion date: Jan 2025 to Oct 2025 Completion date: Dec 2025 to May 2026v9 Show 1 more changeShow less
    • Completion date: Dec 2025 to May 2026
  4. Primary completion date: Aug 2024 to Jan 2025 Completion date: Aug 2024 to Dec 2025v8 Show 1 more changeShow less
    • Completion date: Aug 2024 to Dec 2025
  5. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of May 2024 to May 9, 2024 · Site details revisedv7 Show 2 more changesShow less
    • Start date changed from estimate of May 2024 to May 9, 2024
    • Site details revised
Show 5 earlier versionsHide 5 earlier versions
  1. Start date: Nov 2023 to May 2024 Primary and study completion dates: Feb 2024 to Aug 2024v6 Show 1 more changeShow less
    • Primary and study completion dates: Feb 2024 to Aug 2024
  2. Start date: Jul 2023 to Nov 2023 Primary and study completion dates: Oct 2023 to Feb 2024v5 Show 1 more changeShow less
    • Primary and study completion dates: Oct 2023 to Feb 2024
  3. Primary and study completion dates: Oct 2022 to Oct 2023 Start date: Jul 2022 to Jul 2023v4 Show 1 more changeShow less
    • Start date: Jul 2022 to Jul 2023
  4. Start date: Apr 2022 to Jul 2022v3
  5. Start date: Feb 2022 to Apr 2022 Primary and study completion dates: Aug 2022 to Oct 2022v2 Show 1 more changeShow less
    • Primary and study completion dates: Aug 2022 to Oct 2022
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aesculap AG
32 trials monitored
See 6 trials at risk
Retrospective, monocentric clinical study on the clinical performance of Novosyn® Quick in patients undergoing episiotomy closure.
Trial Details
NCT Number NCT05233527
Lead Sponsor Aesculap AG
Collaborators: B.Braun Surgical SA
Conditions Episiotomy Wound
Enrollment 229 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov